Clarithromycin-based Triple Therapy for Non-Resistant Helicobacter pylori infection. How Long Should It Be Given?

References

• Axon AT, O’Morain CA, Bardhan KD, Crowe JP, Beattie AD, Thompson RP, et al. Randomized double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. BMJ 1997;314:565–8.
   PubMed Web of Science ®Google Scholar
• Van der Hulst RW, Rauws EA, Koycu B, Keller JJ, Bruno MJ, Tijssen JG, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997;113:1082–6.
   PubMed Web of Science ®Google Scholar
• Tucci A, Poli L, Tosetti C, Biasco G, Grigioni W, Varoli O, et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 1998;93:1425–31.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O’Morain C, Bell D, Bianchi PG, Deltenre M, et al. Current European concepts in the management of Helicobacter pylori infection—the Maastricht Consensus Report. The European Helicobacter pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997;9:1–2.
   Google Scholar
• Graham DY. Antibiotic resistance in Helicobacter pylori : implications for therapy. Gastroenterology 1998;115:1272–7.
   PubMed Web of Science ®Google Scholar
• Megraud F, Doermann HP. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut 1998;43 Suppl 1:S61–5.
   PubMed Web of Science ®Google Scholar
• Houben MH, Hensen EF, Rauws EA, Hulst RW, Hoff BW, Ende AV, et al. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains. Aliment Pharmacol Ther 1999;13:883–9.
   PubMed Web of Science ®Google Scholar
• Ducons JA, Santolaria S, Guirao R, Ferrero M, Montoro M, Gomollon F. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori : a prospective study of 1-week lansoprazole, amoxicillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther 1999;13:775–80.
   PubMed Web of Science ®Google Scholar
• Vakil N, Hahn B, McSorley D. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am J Gastroenterol 1998;93:1432–5.
   PubMedGoogle Scholar
• Glupczynski Y. Antimicrobial resistance in Helicobacter pylori: a global overview. Acta Gastroenterol Belg 1998;61:357–66.
   PubMed Web of Science ®Google Scholar
• Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40:477–80.
   PubMed Web of Science ®Google Scholar
• Maeda S, Yoshida H, Matsunaga H, Ogura K, Kawamata O, Shiratori Y, et al. Detection of clarithromycin-resistant Helicobacter pylori strains with preferential homo-duplex formation assay. J Clin Microbiol 2000;38:210–4.
   PubMedGoogle Scholar
• Maeda S, Yoshida H, Ogura K, Kanai F, Shiratori Y, Omata M. Helicobacter pylori-specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 1998;43: 317–21.
   Google Scholar
• Pipkin GA, Williamson R, Wood JR. One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori [Review article]. Aliment Pharmacol Ther 1998;12:823–37.
   Google Scholar
• Grimley CE, Penny A, O’Sullivan M, Shebani M, Lismore JR, Cross R, et al. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. Aliment Pharmacol Ther 1999;13: 869–73.
   PubMedGoogle Scholar
• O’Connor HJ, McLoughlin R, Kelly S, Laundon J, Cunnane K. Lansoprazole triple therapy for Helicobacter pylori—is 5 days enough? Aliment Pharmacol Ther 1998;12: 273–6.
   PubMedGoogle Scholar
• Neville PM, Everett S, Langworthy H, Tompkins D, Mapstone NP, Axon AT, et al. The optimal antibiotic combination in a 5- day Helicobacter pylori eradication regimen. Aliment Pharmacol Ther 1999;13:497–501.
   PubMedGoogle Scholar
• Epple HJ, Kirstein FW, Bojarski C, Frege J, Fromm M, Riecken EO, et al. 13C-urea breath test in Helicobacter pylori diagnosis and eradication. Correlation to histology, origin of ‘false’ results, and influence of food intake. Scand J Gastroenterol 1997;32:308–14.
   Google Scholar
• Murata H, Kawano S, Tsuji S, Tsujii M, Sawaoka H, Iijima H, et al. Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy. Am J Gastroenterol 1998;93:2102–5.
   PubMedGoogle Scholar
• Chu KM, Poon R, Tuen HH, Law SY, Branicki FJ, Wong J. A prospective comparison of locally made rapid urease test and histology for the diagnosis of Helicobacter pylori infection. Gastrointest Endosc 1997;46:503–6.
   PubMedGoogle Scholar
• Yoshida H, Hirota K, Ogura K, Maeda S, Shiratori Y, Sasaki Y, et al. Determination of the optimal cut-off value for [13C] urea breath test based on a Helicobacter pylori-specific PCR assay. J Gastroenterol Hepatol 2000;15:155–160.
   PubMedGoogle Scholar
• Yoshida H, Hirota K, Shiratori Y, Nihei T, Amano S, Yoshida A, et al. Use of a gastric juice-based PCR assay to detect Helicobacter pylori infection in culture-negative patients. J Clin Microbiol 1998;36:317–20.
   PubMedGoogle Scholar
• Oka T, Matsunaga H, Tokunaga K, Mitsunaga S, Juji T, Yamane A. A simple method for detecting single base substitutions and its application to HLA-DPB1 typing. Nucleic Acids Res 1994; 22:1541–7.
   PubMedGoogle Scholar
• Hurenkamp GJ, Van Der Ende A, Grundmeijer HG, Tytgat GN, Van Der Hulst RW. Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer diseases. Aliment Pharmacol Ther 2000;14: 1065–70.
   PubMedGoogle Scholar
• Nagahara A, Miwa H, Ogawa K, Kurosawa A, Ohkura R, Iida N, et al. Addition of metronidazole to rabeprazole-amoxicillin- clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy. Helicobacter 2000;5:88–93.
   PubMed Web of Science ®Google Scholar
• Catalano F, Catanzaro R, Branciforte G, Bentivegna C, Cipolla R, Brogna A, et al. Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up. J Clin Gastroenterol 2000;31:130–6.
   PubMedGoogle Scholar